Aprocitentan Patent Expiration

Aprocitentan was first introduced by Idorsia Pharmaceuticals Ltd in its drug Tryvio on Mar 19, 2024.


Aprocitentan Patents

Given below is the list of patents protecting Aprocitentan, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tryvio US10919881 Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan Feb 26, 2038 Idorsia
Tryvio US11174247 Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases Nov 06, 2037 Idorsia
Tryvio US11680058 Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan Jul 26, 2038 Idorsia
Tryvio US11787782 Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases Mar 02, 2038 Idorsia
Tryvio US8324232 4-pyrimidinesulfamide derivative Sep 21, 2029 Idorsia


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳